-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ(TM) Clinical Program and CNSide(R) Commercial Rollout

Dow Jones·05/15/2026 20:05:00

Please log in to view news